Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 220-410-5 | CAS number: 2756-56-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in chemico
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 18 Apr 2016 to 4 Aug 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 442C (In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA))
- GLP compliance:
- not specified
- Remarks:
- Not specified in report, however, according to the website of the testing laboratory, all assays are performed under GLP
- Type of study:
- direct peptide reactivity assay (DPRA)
Test material
- Reference substance name:
- Exo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl acetate
- EC Number:
- 204-727-6
- EC Name:
- Exo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl acetate
- Cas Number:
- 125-12-2
- Molecular formula:
- C12H20O2
Constituent 1
In chemico test system
- Details on the study design:
- SOLUBILITY TEST
A solubility test was performed for each test article in order to determine an appropriate solvent that completely dissolved the test article at a 100 mM concentration.
PEPTIDE PREPARATION
- Custom synthetic peptides of cysteine or lysine (containing phenylalanine to aid in detection) were used. The purity of each peptide was 90-95%. Peptide samples were newly prepared for each sample set, and a single preparation of the peptide was used throughout the sample set. - The cysteine peptide was prepared by weighing an appropriate amount of the peptide to achieve a 0.667 mM concentration in pH 7.5 phosphate buffer.
- The lysine peptide was prepared by weighing an appropriate amount of the peptide to achieve a 0.667 mM concentration in pH 10.2 ammonium acetate buffer.
- The peptide solutions were gently mixed on the shaker.
PEPTIDE STANDARDS
- A set of serially diluted standards were prepared for each peptide. These standards were prepared by diluting the peptide solutions in dilution buffer (20% acetonitrile in either phosphate or ammonium acetate buffer).
- Six standards were prepared at concentrations of 0.534- 0.0167 mM. A seventh standard was prepared containing only dilution buffer.
- Approximately 1 mL of each standard was pipetted into the appropriate prelabelled autosampler vials.
CONTROLS
- The positive control used in this assay was cinnamic aldehyde prepared at a concentration of 100 mM. The positive control was reacted with the peptides in the same fashion as the test article.
- Reference controls were prepared for each solvent used in the assay. There were three sets of reference controls of acetonitrile run at different points throughout the assay (reference controls A-C). These controls consist of the solvent (acetonitrile) reacted with the peptide in the absence of test article.
- Coelution controls were prepared for each test article. The coelution controls consisted of the test articles without the peptide. The purpose of the coelution controls were to determine if the test article elution from the HPLC column overlapped with the peptide elution.
REACTION MIXTURE PREPARATION
- Immediately prior to testing, each test article was diluted in the appropriate solvent to yield a 100 mM test article concentration. The test articles were mixed as determined during the solubility test (vortexing). The final dosing solutions were prepared for each test article, positive control, and reference control in the prelabelled autosampler vials.
- Triplicate samples were prepared for each test article and control. Single samples were prepared for the coelution controls.
- The make-up of the reaction mixtures was as follows: 1:10 Ratio Cysteine peptide (0.5 mM Peptide, 5 mM test substance) and 1:50 ration Lysine Peptide (0.5 mM Peptide, 25 mM test substance).
HPLC SETUP AND OPERATION
- The separations module used in this assay was a Waters 2690/5 HPLC system. This system consisted of a solvent management system for the mobile phases and a sample management system for the test articles and controls. The HPLC system was coupled to a photodiode array detector set at 220 nm. The dimensions of the column used were 2.1 mm x 100 mm x 3.5 micron. The column was primed for at least 2 hours before the start of the assay. To prime the column, equal parts of mobile phase A (0.1 % TFA in HPLC grade water) and mobile phase B (0.08% TFA in HPLC grade acetonitrile) were passed through the column.
- Once the column was equilibrated and the samples were prepared, the autosampler vials were placed intro the designated location of the separation module carousels. The samples were incubated in the dark at room temperature for 24 ± 2 hours.
- A gradient elution was used in this assay. The mobile phase changed from 10 to 25% acetonitrile over a 10 minute period to allow for optimal separation and gradually elute most of the sample from the column. This was followed by a rapid increase to 90% acetonitrile to remove anything remaining on the column. The column was allowed to equilibrate back to initial specs for 7 minutes between injections.
- The Empower PDA software was used to convert the absorbance data from the UV detector into chromatograms of intensity versus retention time for each sample and control. At the end of the run, each chromatogram was integrated in order for the software to calculate the area under the peptide peak. Cysteine and lysine elute from the column at known times, so it was possible to determine which peaks in the chromatograms represented the peptides and use the areas under those peaks for the subsequent calculations.
CALCULATIONS
- The peak area calculations were obtained from the Empower PDA software and entered into a spreadsheet. Standard curves of peak area versus concentration were prepared for each set of peptide standards. The concentrations were calculated for each sample using peak area and the equation for the appropriate standard curve. The peak area for each sample was substituted for y and the equation was solved for x to determine the peptide concentration of the sample.
- The percent depletion was calculated for each test article sample and the positive control Samples: % peptide depletion = (1 – [test article or positive control peptide peak area / mean peptide peak area of reference control C] x 100). Reference control C consisted of three replicates of acetonitrile and peptide run concurrently with the test article samples.
Results and discussion
- Positive control results:
- The positive control substance Cinnamic Aldehyde caused a mean peptide depletion of 75.4 and 59.8% for Cysteine and Lysine, respectively.
In vitro / in chemico
Resultsopen allclose all
- Parameter:
- other: Mean Peptide depletion of Cysteine and Lysine (%)
- Value:
- 0.2
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- not applicable
- Positive controls validity:
- not applicable
- Remarks on result:
- no indication of skin sensitisation
- Run / experiment:
- other: Mean Percent Peptide Depletion (%)
- Parameter:
- other: Cysteine reactivity
- Value:
- 0.4
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Run / experiment:
- other: Mean Percent Peptide Depletion (%)
- Parameter:
- other: Lysine reactivity
- Value:
- 0
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Other effects / acceptance of results:
- - The substance was found to be soluble in acetonitrile with vortexing for approxirnately 1 minute.
Applicant's summary and conclusion
- Interpretation of results:
- other: Negative
- Conclusions:
- Isobornyl acetate is negative in the DPRA (OECD TG 442C).
- Executive summary:
The Direct Peptide Reactivity Assay (similar to OECD TG 442C) was used in a weight-of-evidence approach to assess the skin sensitizing potential of the test substance. Synthetic peptides containing cysteine or lysine were reacted with 100 mM test article for 24± 2 hours in a ratio of 1:10 (cysteine) or 1:50 (Lysine). Acetonitrile was used as vehicle and Cinnamic aldehyde was used as positive control. After the incubation period the extent of peptide depletion was analyzed using High Performance Liquid Chromatography (HPLC) coupled with ultra-violet (UV) spectrometric detection. The positive control resulted in 75.4 and 59.8% depletion of the respective peptides. The test substance gave a mean peptide depletion of 0.4% and 0.0% for Cysteine and Lysine, respectively. The mean peptide depletion of Cysteine and Lysine was 0.2%. Based on these results, the test is considered negative.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.